# Beth E. Safirstein, M.D. – FDA Inspection, Aug 6, 2019

Source: https://www.keypedia.com/records/fda_inspections/beth-e-safirstein-md/56f744a3-0fd0-4e26-9963-5967f3affe43
Source feed: FDA_Inspections

> FDA inspection 1098747 of Beth E. Safirstein, M.D., August 06, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1098747
- Company Name: Beth E. Safirstein, M.D.
- Inspection Date: 2019-08-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1207723 - 2023-06-05](https://www.keypedia.com/records/fda_inspections/beth-e-safirstein-md/e0595441-9c6a-4d25-a3f5-654b001a98f8)
- [FDA Inspection 585191 - 2009-05-22](https://www.keypedia.com/records/fda_inspections/beth-e-safirstein-md/a2bc7837-fa31-463e-8d12-c0e5973192d5)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/traci-m-armand/3af556f9-942c-4e58-85ee-f7d261a236ce)

Company: https://www.keypedia.com/companies/beth-e-safirstein-md/9fdf7e95-e050-4f9d-bcd2-e00665e881c1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c